Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank82
3Y CAGR-7.0%
5Y CAGR+5.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.0%/yr
vs +19.1%/yr prior
5Y CAGR
+5.8%/yr
Recent deceleration
Acceleration
-26.1pp
Decelerating
Percentile
P82
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $713.00M | -7.5% |
| 2024 | $771.11M | +16.9% |
| 2023 | $659.50M | -25.6% |
| 2022 | $886.39M | +43.8% |
| 2021 | $616.26M | +14.7% |
| 2020 | $537.24M | -10.7% |
| 2019 | $601.68M | +36.5% |
| 2018 | $440.89M | +46.5% |
| 2017 | $300.98M | -7.0% |
| 2016 | $323.50M | - |